NASDAQ:TMDITitan Medical Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Titan Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $0.21 -0.04 (-15.84 %) (As of 04/5/2020 01:43 PM ET) Add Compare Share Today's Range$0.20Now: $0.21▼$0.2350-Day Range$0.15MA: $0.30▼$0.4352-Week Range$0.12Now: $0.21▼$3.14Volume736,318 shsAverage Volume4.09 million shsMarket Capitalization$11.02 millionP/E RatioN/ADividend YieldN/ABeta3.5 ProfileAnalyst RatingsAdvanced ChartEarningsInstitutional OwnershipHeadlinesSocial Media Titan Medical Inc., a research and development stage company, focuses on the design, development, and commercialization of computer-assisted robotic surgical technologies for application in minimally invasive surgery (MIS). The company is developing the SPORT Surgical System, a single-port robotic surgical system that comprises a surgeon-controlled patient cart, which includes a 3D vision system and multi-articulating instruments for performing MIS procedures; and a surgeon workstation that provides the surgeon with ergonomic interface to the patient cart and a 3D endoscopic view inside the patient's body during MIS procedures. The SPORT Surgical System enables surgeons to perform surgical procedures for gynecologic, urologic, colorectal, and general abdominal indications. Titan Medical Inc. is headquartered in Toronto, Canada.Read More Beat the Market (BTM) Rank™ 3.3 Analyst's Opinion Consensus RatingTitan Medical has received a consensus rating of Buy. The company's average rating score is 2.67, and is based on 2 buy ratings, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $1.25, Titan Medical has a potential upside of 488.0% from its current price of $0.21.Amount of Analyst CoverageTitan Medical has only been the subject of 1 research reports in the past 90 days. Previous Next 2.4 Community Rank Outperform VotesTitan Medical has received 138 “outperform” votes. (Add your “outperform” vote.)Underperform VotesTitan Medical has received 148 “underperform” votes. (Add your “underperform” vote.)Community SentimentTitan Medical has received 51.75% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Titan Medical and other stocks. Vote “Outperform” if you believe TMDI will outperform the S&P 500 over the long term. Vote “Underperform” if you believe TMDI will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldTitan Medical does not currently pay a dividend.Dividend GrowthTitan Medical does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Titan Medical insiders have not sold or bought any company stock.Percentage Held by InstitutionsOnly 5.14% of the stock of Titan Medical is held by institutions. Previous Next 0.0 Earnings and Valuation Earnings GrowthEarnings for Titan Medical are expected to decrease by 0.00% in the coming year, from ($0.51) to ($0.51) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Titan Medical is -0.29, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Titan Medical is -0.29, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioTitan Medical has a P/B Ratio of 1.12. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next Analyst Opinion: 3.3Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.15 out of 5 stars Industry, Sector and Symbol Stock Exchange NASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:TMDI Previous Symbol CUSIPN/A CIKN/A Webhttp://www.titanmedicalinc.com/ Phone416-548-7522Debt Debt-to-Equity RatioN/A Current Ratio0.19 Quick Ratio0.19Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$0.19 per share Price / Book1.12Profitability EPS (Most Recent Fiscal Year)($1.95) Net Income$-22,640,000.00 Net MarginsN/A Return on EquityN/A Return on Assets-165.51%Miscellaneous Employees9 Outstanding Shares51,820,000Market Cap$11.02 million Next Earnings Date5/12/2020 (Estimated) OptionableNot Optionable Receive TMDI News and Ratings via Email Sign-up to receive the latest news and ratings for TMDI and its competitors with MarketBeat's FREE daily newsletter. NASDAQ:TMDI Rates by TradingView Titan Medical (NASDAQ:TMDI) Frequently Asked Questions How has Titan Medical's stock been impacted by COVID-19 (Coronavirus)? Titan Medical's stock was trading at $0.20 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, TMDI stock has increased by 6.3% and is now trading at $0.2126. View which stocks have been mosted impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of Titan Medical? 3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Titan Medical in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Titan Medical. When is Titan Medical's next earnings date? Titan Medical is scheduled to release its next quarterly earnings announcement on Tuesday, May 12th 2020. View our earnings forecast for Titan Medical. What price target have analysts set for TMDI? 3 brokers have issued 12 month price objectives for Titan Medical's stock. Their forecasts range from $1.00 to $1.50. On average, they anticipate Titan Medical's stock price to reach $1.25 in the next twelve months. This suggests a possible upside of 488.0% from the stock's current price. View analysts' price targets for Titan Medical. Has Titan Medical been receiving favorable news coverage? News coverage about TMDI stock has trended very negative recently, InfoTrie reports. InfoTrie ranks the sentiment of news coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Titan Medical earned a media sentiment score of -3.3 on InfoTrie's scale. They also gave news articles about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View the latest news aboutTitan Medical. Are investors shorting Titan Medical? Titan Medical saw a increase in short interest during the month of March. As of March 13th, there was short interest totaling 670,600 shares, an increase of 17.6% from the February 27th total of 570,400 shares. Based on an average daily trading volume, of 481,900 shares, the days-to-cover ratio is presently 1.4 days. Currently, 1.7% of the company's shares are sold short. View Titan Medical's Current Options Chain. Who are some of Titan Medical's key competitors? Some companies that are related to Titan Medical include Apollo Endosurgery (APEN), Sensus Healthcare (SRTS), Arch Therapeutics (ARTH), Delcath Systems (DCTH), Biostage (BSTG), Invo Bioscience (IVOB), Neuronetics (STIM), STRATA Skin Sciences (SSKN), T2 Biosystems (TTOO), Interpace Diagnostics Group (IDXG), RA Medical Systems (RMED), Motus GI (MOTS), DarioHealth (DRIO), Neovasc (NVCN) and Endologix (ELGX). What other stocks do shareholders of Titan Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Titan Medical investors own include Inovio Pharmaceuticals (INO), Alibaba Group (BABA), Corbus Pharmaceuticals (CRBP), Krystal Biotech (KRYS), Micron Technology (MU), Progenics Pharmaceuticals (PGNX), Sorrento Therapeutics (SRNE), Viking Therapeutics (VKTX), Zynerba Pharmaceuticals (ZYNE) and British American Tobacco (BTI). Who are Titan Medical's key executives? Titan Medical's management team includes the following people: Mr. David J. McNally, Pres, CEO & Director (Age 57)Mr. Stephen D. Randall, CFO, Sec. & DirectorDr. Perry A. Genova, Sr. VP of R&DMr. Curtis R. Jensen, VP of Quality & Regulatory AffairsMr. Sachin A. Sankholkar, VP of Marketing What is Titan Medical's stock symbol? Titan Medical trades on the NASDAQ under the ticker symbol "TMDI." How do I buy shares of Titan Medical? Shares of TMDI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Titan Medical's stock price today? One share of TMDI stock can currently be purchased for approximately $0.21. How big of a company is Titan Medical? Titan Medical has a market capitalization of $11.02 million. The company earns $-22,640,000.00 in net income (profit) each year or ($1.95) on an earnings per share basis. Titan Medical employs 9 workers across the globe. View additional information about Titan Medical. What is Titan Medical's official website? The official website for Titan Medical is http://www.titanmedicalinc.com/. How can I contact Titan Medical? Titan Medical's mailing address is 170 UNIVERSITY AVENUE, TORONTO A6, M5H 3B3. The company can be reached via phone at 416-548-7522. This page was last updated on 4/5/2020 by MarketBeat.com StaffFeatured Article: Hedge Funds - Risk or Reward?
